SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-232463
Filing Date
2018-07-31 09:00:38
Period of Report
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d553566d8k.htm 8-K 31331
2 EX-3.1 d553566dex31.htm EX-3.1 4691
3 EX-3.2 d553566dex32.htm EX-3.2 66505
  Complete submission text file 0001193125-18-232463.txt   104188
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Filer) CIK: 0001488613 (see all company filings)

IRS No.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36086 | Film No.: 18979610
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences